Related Experiment Video
Updated: Jul 3, 2026

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology
Published on: May 26, 2015
[Late recurrences of atrial fibrillation in patients after direct-current cardioversion]
M Gurciková1, J Kaluzay, S Remisová
1IV. Interná klinika Lekárskej fakulty UK a FNsP Bratislava, Slovenská republika. marcela.gurcikova@gmail.com
Insights
Successful cardioversion for atrial fibrillation (AF) does not prevent recurrence, with nearly half of patients experiencing late AF. Females, those with thyroid issues, and higher blood pressure post-procedure face increased recurrence risk.
Area of Science:
- Cardiology
- Electrophysiology
Context:
- Atrial fibrillation (AF) is a common arrhythmia.
- Direct-current cardioversion is a treatment option for restoring sinus rhythm.
- Understanding long-term outcomes after cardioversion is crucial for patient management.
Purpose:
- To analyze factors associated with late recurrence of atrial fibrillation (AF) after successful direct-current cardioversion.
- To identify patient subgroups at higher risk for AF relapse.
Summary:
- A retrospective analysis of 43 patients with AF found a 46.5% late recurrence rate after direct-current cardioversion.
- Recurrence was more frequent in females, patients with a history of thyropathy, and those with elevated post-cardioversion systolic and pulse pressures.
- Median time to recurrence was 15 months, with significant relapse occurring beyond one year.
Impact:
- Highlights the significant risk of late AF recurrence despite successful cardioversion.
- Identifies key demographic and clinical factors (female sex, thyropathy history, elevated blood pressure) predicting higher recurrence risk.
- Informs clinical practice regarding patient selection, monitoring, and risk stratification post-cardioversion.
Aim:
To analyze factors after successful direct-current cardioversion in patients with atrial fibrillation and to explore late recurrences of the arrhythmia.
Methods:
Forty-three patients with atrial fibrillation without associated valvular heart disease, who underwent non-emergent cardioversion within the years 2002-2006, were included. We retrospectively analyzed clinical data from the medical records. Late reccurence of the arrhythmia was defined as arrhythmia in patients discharged with sinus rhythm.
Results:
Median follow-up of the patients was 33 (17, 48) months. We found 20 late recurrences of atrial fibrillation in the total group of 43 patients after successful direct-current cardioversion (46.5%). In a 6-month period after direct-current cardioversion the recurrence of arrhythmia was found in two patients, in a one-year period in 6 patients and in a period longer than one year in 12 patients. Median time to recurrence was 15 (6, 33) months. Females relapsed more frequently than males (p < 0.02), what could be explained by higher age, incidence of hypertension and thyreopathy in females. Patients with a history of thyropathy had more frequent occurrence of arrhythmia, despite normal values of TSH, as compared to patients without a history of thyropathy (p < 0.04). Patients with recurrence of the atrial fibrillation had higher systolic pressure (130 vs 120 mm Hg, p < 0.05) and pulse arterial pressure (50 vs 40 mm Hg, p < 0.01) after cardioversion. No significant difference between the two groups in age, left atrium diameter, left ventricle ejection fraction and cardiovascular, or non-cardiovascular risk factors was found.
Conclusion:
Despite successful direct-current cardioversion, the risk of late recurrence of the atrial fibrillation in a following period is at least 46.5%. Females, patients with a history of thyropathy and those with higher systolic and pulse arterial pressures are at higher risk of late recurrences.
Related Concept Videos
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Dysrhythmias VI: Management of Dysrhythmias
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiopulmonary Resuscitation III: AED Use
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...

